報價延遲最少15分鐘:2026/06/03 00:21 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
15.18 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
35.34/226.33
|
|
企業價值
4,014.32B
|
| 資產負債 |
|
每股賬面淨值
15.42
|
| 現金流量 |
|
現金流量率
0.13
|
| 損益表 |
|
收益
1,508.93B
|
|
每股收益
8.80
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada. |
